|
|||
|
|
|
|
|
|
||||
|
|
|
||||||
|
View media coverage of Dr. Carlat and TCPR. And click here to read his blog on psychiatry and the pharmaceutical industry.
TCPR July/August 2008
Much of what is confusing and controversial in the treatment of bipolar disorder revolves around the role of antidepressants. Are they dangerous or safe? Are they effective or ineffective? Does it matter whether the patient has Bipolar I or II? (Free)
TCPR May 2008
Most psychiatrists rely on the Folstein Mini Mental State Exam for a rapid, office-based neuropsycholgical assessment. But a hot new test, called the Montreal Cognitive Assessment (MoCA) appears to work much better. (Subscription required)
TCPR April 2008
After many years of trying, Wyeth finally received FDA approval for its new antidepressant, Pristiq (desvenlafaxine). Don't get too excited though-Pristiq is simply the active metabolite of Effexor... (Subscription required)
TCPR March 2008
The National Institute on Alcohol Abuse and Alcoholism has recently posted a practical guide for professional interested in improving their skills in evaluating and treating patients with alcohol problems. Learn more here… (Free.)
TCPR February 2008
In this article, TCPR reviews the clinical data on three of the most frequently used of the novel anticonvulsants. (Subscription required)
TCPR December 2007
"To sleep, perchance to dream-ay, there is the rub." Hamlet may have feared sleep, but for the millions of Americans suffering from chronic sleeping problems, they fear not sleeping. Clearly sleeping pills work, find out here whether there are significant differences among them. (Subscription required)
TCPR September 2007
Most psychiatrists prescribe SSRIs as the first-line medication for depression, but what's the best option when this strategy is ineffective? Here's a run-down of the best antidepressant combinations. (Free)
TCPR March 2007
Invega (paliperidone) is the newest antipsychotic to be approved by the FDA. But is it really new? In this article, we analyze the pros and cons of Invega, particularly in comparison with its mother compund, risperidone. (Free)
TCPR October 2007
While few pyschiatrists specialize in eating disorders, most of see patitents with anorexia or bulemia from time to time. It's hard to keep up on the latest literature when we see such patients rarely. Here's an update on issues of diagnosis and treatment. (Free)
|
|
|
|||||
|
||||||||
|
|
Featured Articles
